There are currently no efficient treatments or cures available, but a number of promising clinical trials are under way and the charity has contributed to crucial scientific breakthroughs. These include the technology of 'exon skipping' which might help boys with Duchenne muscular dystrophy. They have also funded work that has led to a breakthrough in treatment for mitochondrial myopathy.
St George, a company within the Berkeley Group, has been a supporter for over 10 years. Their staff compete in an annual 10k run to raise funds for this cause. A staff members daughter, who herself suffers from myotonic dystrophy, took part in a 'Move a Mile' walk for the charity, raising over £1000 for the charity.
Their donations, combined with a grant from the Berkeley Foundation, are helping in five key areas: world-class research to find effective treatments and cures; practical advice and emotional support for individuals; awareness raising; specialist equipment, such as powered wheelchairs; and specialist education for health professionals.